A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

Recruiting

Phase 3

PG4 vs. 20vPnCA Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

Sponsor:

Pfizer

Code:

NCT07573462

Conditions

Pneumococcal Disease

Eligibility Criteria

Sex: All

Age: 0

Healthy Volunteers: Accepted

Interventions

PG4

20-valent pneumococcal conjugate vaccine (20vPnC)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-29. This information was provided to ClinicalTrials.gov by Pfizer on 2026-05-27.